Medical Care

Global IgG4 Antibody Market Research Report 2025

This report aims to provide a comprehensive presentation of the global market for IgG4 Antibody, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding IgG4 Antibody.
The IgG4 Antibody market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global IgG4 Antibody market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the IgG4 Antibody companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio X Cell
SouthernBiotech
MyBioSource
BosterBio
Biorbyt
BioLegend
Novus Biologicals
Sino Biological
RevMAb Biosciences
RayBiotech
ichorbio
Absolute Antibody
AntibodySystem
Thermo Fisher Scientific
Affinity Immuno
Dianova
Southern Biotech
Leinco Technologies
Abnova Corporation
Kyinno
Cell Sciences
ProSci
Bio-Rad
United States Biological
DIMA Biotechnology
OriGene Technologies
Abeomics
Cayman Chemical
R&D Systems
Biomatik
Segment by Type
Monoclonal Antibody
Polyclonal Antibody
Segment by Application
Biotechnology
Medical
University
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of IgG4 Antibody company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global IgG4 Antibody Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Monoclonal Antibody
1.2.3 Polyclonal Antibody
1.3 Market by Application
1.3.1 Global IgG4 Antibody Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Biotechnology
1.3.3 Medical
1.3.4 University
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global IgG4 Antibody Market Perspective (2020-2031)
2.2 Global IgG4 Antibody Growth Trends by Region
2.2.1 Global IgG4 Antibody Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 IgG4 Antibody Historic Market Size by Region (2020-2025)
2.2.3 IgG4 Antibody Forecasted Market Size by Region (2026-2031)
2.3 IgG4 Antibody Market Dynamics
2.3.1 IgG4 Antibody Industry Trends
2.3.2 IgG4 Antibody Market Drivers
2.3.3 IgG4 Antibody Market Challenges
2.3.4 IgG4 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top IgG4 Antibody Players by Revenue
3.1.1 Global Top IgG4 Antibody Players by Revenue (2020-2025)
3.1.2 Global IgG4 Antibody Revenue Market Share by Players (2020-2025)
3.2 Global IgG4 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by IgG4 Antibody Revenue
3.4 Global IgG4 Antibody Market Concentration Ratio
3.4.1 Global IgG4 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by IgG4 Antibody Revenue in 2024
3.5 Global Key Players of IgG4 Antibody Head office and Area Served
3.6 Global Key Players of IgG4 Antibody, Product and Application
3.7 Global Key Players of IgG4 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 IgG4 Antibody Breakdown Data by Type
4.1 Global IgG4 Antibody Historic Market Size by Type (2020-2025)
4.2 Global IgG4 Antibody Forecasted Market Size by Type (2026-2031)
5 IgG4 Antibody Breakdown Data by Application
5.1 Global IgG4 Antibody Historic Market Size by Application (2020-2025)
5.2 Global IgG4 Antibody Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America IgG4 Antibody Market Size (2020-2031)
6.2 North America IgG4 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America IgG4 Antibody Market Size by Country (2020-2025)
6.4 North America IgG4 Antibody Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe IgG4 Antibody Market Size (2020-2031)
7.2 Europe IgG4 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe IgG4 Antibody Market Size by Country (2020-2025)
7.4 Europe IgG4 Antibody Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific IgG4 Antibody Market Size (2020-2031)
8.2 Asia-Pacific IgG4 Antibody Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific IgG4 Antibody Market Size by Region (2020-2025)
8.4 Asia-Pacific IgG4 Antibody Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America IgG4 Antibody Market Size (2020-2031)
9.2 Latin America IgG4 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America IgG4 Antibody Market Size by Country (2020-2025)
9.4 Latin America IgG4 Antibody Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa IgG4 Antibody Market Size (2020-2031)
10.2 Middle East & Africa IgG4 Antibody Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa IgG4 Antibody Market Size by Country (2020-2025)
10.4 Middle East & Africa IgG4 Antibody Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio X Cell
11.1.1 Bio X Cell Company Details
11.1.2 Bio X Cell Business Overview
11.1.3 Bio X Cell IgG4 Antibody Introduction
11.1.4 Bio X Cell Revenue in IgG4 Antibody Business (2020-2025)
11.1.5 Bio X Cell Recent Development
11.2 SouthernBiotech
11.2.1 SouthernBiotech Company Details
11.2.2 SouthernBiotech Business Overview
11.2.3 SouthernBiotech IgG4 Antibody Introduction
11.2.4 SouthernBiotech Revenue in IgG4 Antibody Business (2020-2025)
11.2.5 SouthernBiotech Recent Development
11.3 MyBioSource
11.3.1 MyBioSource Company Details
11.3.2 MyBioSource Business Overview
11.3.3 MyBioSource IgG4 Antibody Introduction
11.3.4 MyBioSource Revenue in IgG4 Antibody Business (2020-2025)
11.3.5 MyBioSource Recent Development
11.4 BosterBio
11.4.1 BosterBio Company Details
11.4.2 BosterBio Business Overview
11.4.3 BosterBio IgG4 Antibody Introduction
11.4.4 BosterBio Revenue in IgG4 Antibody Business (2020-2025)
11.4.5 BosterBio Recent Development
11.5 Biorbyt
11.5.1 Biorbyt Company Details
11.5.2 Biorbyt Business Overview
11.5.3 Biorbyt IgG4 Antibody Introduction
11.5.4 Biorbyt Revenue in IgG4 Antibody Business (2020-2025)
11.5.5 Biorbyt Recent Development
11.6 BioLegend
11.6.1 BioLegend Company Details
11.6.2 BioLegend Business Overview
11.6.3 BioLegend IgG4 Antibody Introduction
11.6.4 BioLegend Revenue in IgG4 Antibody Business (2020-2025)
11.6.5 BioLegend Recent Development
11.7 Novus Biologicals
11.7.1 Novus Biologicals Company Details
11.7.2 Novus Biologicals Business Overview
11.7.3 Novus Biologicals IgG4 Antibody Introduction
11.7.4 Novus Biologicals Revenue in IgG4 Antibody Business (2020-2025)
11.7.5 Novus Biologicals Recent Development
11.8 Sino Biological
11.8.1 Sino Biological Company Details
11.8.2 Sino Biological Business Overview
11.8.3 Sino Biological IgG4 Antibody Introduction
11.8.4 Sino Biological Revenue in IgG4 Antibody Business (2020-2025)
11.8.5 Sino Biological Recent Development
11.9 RevMAb Biosciences
11.9.1 RevMAb Biosciences Company Details
11.9.2 RevMAb Biosciences Business Overview
11.9.3 RevMAb Biosciences IgG4 Antibody Introduction
11.9.4 RevMAb Biosciences Revenue in IgG4 Antibody Business (2020-2025)
11.9.5 RevMAb Biosciences Recent Development
11.10 RayBiotech
11.10.1 RayBiotech Company Details
11.10.2 RayBiotech Business Overview
11.10.3 RayBiotech IgG4 Antibody Introduction
11.10.4 RayBiotech Revenue in IgG4 Antibody Business (2020-2025)
11.10.5 RayBiotech Recent Development
11.11 ichorbio
11.11.1 ichorbio Company Details
11.11.2 ichorbio Business Overview
11.11.3 ichorbio IgG4 Antibody Introduction
11.11.4 ichorbio Revenue in IgG4 Antibody Business (2020-2025)
11.11.5 ichorbio Recent Development
11.12 Absolute Antibody
11.12.1 Absolute Antibody Company Details
11.12.2 Absolute Antibody Business Overview
11.12.3 Absolute Antibody IgG4 Antibody Introduction
11.12.4 Absolute Antibody Revenue in IgG4 Antibody Business (2020-2025)
11.12.5 Absolute Antibody Recent Development
11.13 AntibodySystem
11.13.1 AntibodySystem Company Details
11.13.2 AntibodySystem Business Overview
11.13.3 AntibodySystem IgG4 Antibody Introduction
11.13.4 AntibodySystem Revenue in IgG4 Antibody Business (2020-2025)
11.13.5 AntibodySystem Recent Development
11.14 Thermo Fisher Scientific
11.14.1 Thermo Fisher Scientific Company Details
11.14.2 Thermo Fisher Scientific Business Overview
11.14.3 Thermo Fisher Scientific IgG4 Antibody Introduction
11.14.4 Thermo Fisher Scientific Revenue in IgG4 Antibody Business (2020-2025)
11.14.5 Thermo Fisher Scientific Recent Development
11.15 Affinity Immuno
11.15.1 Affinity Immuno Company Details
11.15.2 Affinity Immuno Business Overview
11.15.3 Affinity Immuno IgG4 Antibody Introduction
11.15.4 Affinity Immuno Revenue in IgG4 Antibody Business (2020-2025)
11.15.5 Affinity Immuno Recent Development
11.16 Dianova
11.16.1 Dianova Company Details
11.16.2 Dianova Business Overview
11.16.3 Dianova IgG4 Antibody Introduction
11.16.4 Dianova Revenue in IgG4 Antibody Business (2020-2025)
11.16.5 Dianova Recent Development
11.17 Southern Biotech
11.17.1 Southern Biotech Company Details
11.17.2 Southern Biotech Business Overview
11.17.3 Southern Biotech IgG4 Antibody Introduction
11.17.4 Southern Biotech Revenue in IgG4 Antibody Business (2020-2025)
11.17.5 Southern Biotech Recent Development
11.18 Leinco Technologies
11.18.1 Leinco Technologies Company Details
11.18.2 Leinco Technologies Business Overview
11.18.3 Leinco Technologies IgG4 Antibody Introduction
11.18.4 Leinco Technologies Revenue in IgG4 Antibody Business (2020-2025)
11.18.5 Leinco Technologies Recent Development
11.19 Abnova Corporation
11.19.1 Abnova Corporation Company Details
11.19.2 Abnova Corporation Business Overview
11.19.3 Abnova Corporation IgG4 Antibody Introduction
11.19.4 Abnova Corporation Revenue in IgG4 Antibody Business (2020-2025)
11.19.5 Abnova Corporation Recent Development
11.20 Kyinno
11.20.1 Kyinno Company Details
11.20.2 Kyinno Business Overview
11.20.3 Kyinno IgG4 Antibody Introduction
11.20.4 Kyinno Revenue in IgG4 Antibody Business (2020-2025)
11.20.5 Kyinno Recent Development
11.21 Cell Sciences
11.21.1 Cell Sciences Company Details
11.21.2 Cell Sciences Business Overview
11.21.3 Cell Sciences IgG4 Antibody Introduction
11.21.4 Cell Sciences Revenue in IgG4 Antibody Business (2020-2025)
11.21.5 Cell Sciences Recent Development
11.22 ProSci
11.22.1 ProSci Company Details
11.22.2 ProSci Business Overview
11.22.3 ProSci IgG4 Antibody Introduction
11.22.4 ProSci Revenue in IgG4 Antibody Business (2020-2025)
11.22.5 ProSci Recent Development
11.23 Bio-Rad
11.23.1 Bio-Rad Company Details
11.23.2 Bio-Rad Business Overview
11.23.3 Bio-Rad IgG4 Antibody Introduction
11.23.4 Bio-Rad Revenue in IgG4 Antibody Business (2020-2025)
11.23.5 Bio-Rad Recent Development
11.24 United States Biological
11.24.1 United States Biological Company Details
11.24.2 United States Biological Business Overview
11.24.3 United States Biological IgG4 Antibody Introduction
11.24.4 United States Biological Revenue in IgG4 Antibody Business (2020-2025)
11.24.5 United States Biological Recent Development
11.25 DIMA Biotechnology
11.25.1 DIMA Biotechnology Company Details
11.25.2 DIMA Biotechnology Business Overview
11.25.3 DIMA Biotechnology IgG4 Antibody Introduction
11.25.4 DIMA Biotechnology Revenue in IgG4 Antibody Business (2020-2025)
11.25.5 DIMA Biotechnology Recent Development
11.26 OriGene Technologies
11.26.1 OriGene Technologies Company Details
11.26.2 OriGene Technologies Business Overview
11.26.3 OriGene Technologies IgG4 Antibody Introduction
11.26.4 OriGene Technologies Revenue in IgG4 Antibody Business (2020-2025)
11.26.5 OriGene Technologies Recent Development
11.27 Abeomics
11.27.1 Abeomics Company Details
11.27.2 Abeomics Business Overview
11.27.3 Abeomics IgG4 Antibody Introduction
11.27.4 Abeomics Revenue in IgG4 Antibody Business (2020-2025)
11.27.5 Abeomics Recent Development
11.28 Cayman Chemical
11.28.1 Cayman Chemical Company Details
11.28.2 Cayman Chemical Business Overview
11.28.3 Cayman Chemical IgG4 Antibody Introduction
11.28.4 Cayman Chemical Revenue in IgG4 Antibody Business (2020-2025)
11.28.5 Cayman Chemical Recent Development
11.29 R&D Systems
11.29.1 R&D Systems Company Details
11.29.2 R&D Systems Business Overview
11.29.3 R&D Systems IgG4 Antibody Introduction
11.29.4 R&D Systems Revenue in IgG4 Antibody Business (2020-2025)
11.29.5 R&D Systems Recent Development
11.30 Biomatik
11.30.1 Biomatik Company Details
11.30.2 Biomatik Business Overview
11.30.3 Biomatik IgG4 Antibody Introduction
11.30.4 Biomatik Revenue in IgG4 Antibody Business (2020-2025)
11.30.5 Biomatik Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global IgG4 Antibody Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Monoclonal Antibody
Table 3. Key Players of Polyclonal Antibody
Table 4. Global IgG4 Antibody Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 5. Global IgG4 Antibody Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global IgG4 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 7. Global IgG4 Antibody Market Share by Region (2020-2025)
Table 8. Global IgG4 Antibody Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 9. Global IgG4 Antibody Market Share by Region (2026-2031)
Table 10. IgG4 Antibody Market Trends
Table 11. IgG4 Antibody Market Drivers
Table 12. IgG4 Antibody Market Challenges
Table 13. IgG4 Antibody Market Restraints
Table 14. Global IgG4 Antibody Revenue by Players (2020-2025) & (US$ Million)
Table 15. Global IgG4 Antibody Market Share by Players (2020-2025)
Table 16. Global Top IgG4 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgG4 Antibody as of 2024)
Table 17. Ranking of Global Top IgG4 Antibody Companies by Revenue (US$ Million) in 2024
Table 18. Global 5 Largest Players Market Share by IgG4 Antibody Revenue (CR5 and HHI) & (2020-2025)
Table 19. Global Key Players of IgG4 Antibody, Headquarters and Area Served
Table 20. Global Key Players of IgG4 Antibody, Product and Application
Table 21. Global Key Players of IgG4 Antibody, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global IgG4 Antibody Market Size by Type (2020-2025) & (US$ Million)
Table 24. Global IgG4 Antibody Revenue Market Share by Type (2020-2025)
Table 25. Global IgG4 Antibody Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 26. Global IgG4 Antibody Revenue Market Share by Type (2026-2031)
Table 27. Global IgG4 Antibody Market Size by Application (2020-2025) & (US$ Million)
Table 28. Global IgG4 Antibody Revenue Market Share by Application (2020-2025)
Table 29. Global IgG4 Antibody Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 30. Global IgG4 Antibody Revenue Market Share by Application (2026-2031)
Table 31. North America IgG4 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 32. North America IgG4 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 33. North America IgG4 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 34. Europe IgG4 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. Europe IgG4 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 36. Europe IgG4 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 37. Asia-Pacific IgG4 Antibody Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 38. Asia-Pacific IgG4 Antibody Market Size by Region (2020-2025) & (US$ Million)
Table 39. Asia-Pacific IgG4 Antibody Market Size by Region (2026-2031) & (US$ Million)
Table 40. Latin America IgG4 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 41. Latin America IgG4 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 42. Latin America IgG4 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 43. Middle East & Africa IgG4 Antibody Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Middle East & Africa IgG4 Antibody Market Size by Country (2020-2025) & (US$ Million)
Table 45. Middle East & Africa IgG4 Antibody Market Size by Country (2026-2031) & (US$ Million)
Table 46. Bio X Cell Company Details
Table 47. Bio X Cell Business Overview
Table 48. Bio X Cell IgG4 Antibody Product
Table 49. Bio X Cell Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 50. Bio X Cell Recent Development
Table 51. SouthernBiotech Company Details
Table 52. SouthernBiotech Business Overview
Table 53. SouthernBiotech IgG4 Antibody Product
Table 54. SouthernBiotech Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 55. SouthernBiotech Recent Development
Table 56. MyBioSource Company Details
Table 57. MyBioSource Business Overview
Table 58. MyBioSource IgG4 Antibody Product
Table 59. MyBioSource Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 60. MyBioSource Recent Development
Table 61. BosterBio Company Details
Table 62. BosterBio Business Overview
Table 63. BosterBio IgG4 Antibody Product
Table 64. BosterBio Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 65. BosterBio Recent Development
Table 66. Biorbyt Company Details
Table 67. Biorbyt Business Overview
Table 68. Biorbyt IgG4 Antibody Product
Table 69. Biorbyt Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 70. Biorbyt Recent Development
Table 71. BioLegend Company Details
Table 72. BioLegend Business Overview
Table 73. BioLegend IgG4 Antibody Product
Table 74. BioLegend Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 75. BioLegend Recent Development
Table 76. Novus Biologicals Company Details
Table 77. Novus Biologicals Business Overview
Table 78. Novus Biologicals IgG4 Antibody Product
Table 79. Novus Biologicals Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 80. Novus Biologicals Recent Development
Table 81. Sino Biological Company Details
Table 82. Sino Biological Business Overview
Table 83. Sino Biological IgG4 Antibody Product
Table 84. Sino Biological Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 85. Sino Biological Recent Development
Table 86. RevMAb Biosciences Company Details
Table 87. RevMAb Biosciences Business Overview
Table 88. RevMAb Biosciences IgG4 Antibody Product
Table 89. RevMAb Biosciences Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 90. RevMAb Biosciences Recent Development
Table 91. RayBiotech Company Details
Table 92. RayBiotech Business Overview
Table 93. RayBiotech IgG4 Antibody Product
Table 94. RayBiotech Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 95. RayBiotech Recent Development
Table 96. ichorbio Company Details
Table 97. ichorbio Business Overview
Table 98. ichorbio IgG4 Antibody Product
Table 99. ichorbio Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 100. ichorbio Recent Development
Table 101. Absolute Antibody Company Details
Table 102. Absolute Antibody Business Overview
Table 103. Absolute Antibody IgG4 Antibody Product
Table 104. Absolute Antibody Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 105. Absolute Antibody Recent Development
Table 106. AntibodySystem Company Details
Table 107. AntibodySystem Business Overview
Table 108. AntibodySystem IgG4 Antibody Product
Table 109. AntibodySystem Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 110. AntibodySystem Recent Development
Table 111. Thermo Fisher Scientific Company Details
Table 112. Thermo Fisher Scientific Business Overview
Table 113. Thermo Fisher Scientific IgG4 Antibody Product
Table 114. Thermo Fisher Scientific Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 115. Thermo Fisher Scientific Recent Development
Table 116. Affinity Immuno Company Details
Table 117. Affinity Immuno Business Overview
Table 118. Affinity Immuno IgG4 Antibody Product
Table 119. Affinity Immuno Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 120. Affinity Immuno Recent Development
Table 121. Dianova Company Details
Table 122. Dianova Business Overview
Table 123. Dianova IgG4 Antibody Product
Table 124. Dianova Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 125. Dianova Recent Development
Table 126. Southern Biotech Company Details
Table 127. Southern Biotech Business Overview
Table 128. Southern Biotech IgG4 Antibody Product
Table 129. Southern Biotech Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 130. Southern Biotech Recent Development
Table 131. Leinco Technologies Company Details
Table 132. Leinco Technologies Business Overview
Table 133. Leinco Technologies IgG4 Antibody Product
Table 134. Leinco Technologies Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 135. Leinco Technologies Recent Development
Table 136. Abnova Corporation Company Details
Table 137. Abnova Corporation Business Overview
Table 138. Abnova Corporation IgG4 Antibody Product
Table 139. Abnova Corporation Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 140. Abnova Corporation Recent Development
Table 141. Kyinno Company Details
Table 142. Kyinno Business Overview
Table 143. Kyinno IgG4 Antibody Product
Table 144. Kyinno Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 145. Kyinno Recent Development
Table 146. Cell Sciences Company Details
Table 147. Cell Sciences Business Overview
Table 148. Cell Sciences IgG4 Antibody Product
Table 149. Cell Sciences Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 150. Cell Sciences Recent Development
Table 151. ProSci Company Details
Table 152. ProSci Business Overview
Table 153. ProSci IgG4 Antibody Product
Table 154. ProSci Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 155. ProSci Recent Development
Table 156. Bio-Rad Company Details
Table 157. Bio-Rad Business Overview
Table 158. Bio-Rad IgG4 Antibody Product
Table 159. Bio-Rad Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 160. Bio-Rad Recent Development
Table 161. United States Biological Company Details
Table 162. United States Biological Business Overview
Table 163. United States Biological IgG4 Antibody Product
Table 164. United States Biological Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 165. United States Biological Recent Development
Table 166. DIMA Biotechnology Company Details
Table 167. DIMA Biotechnology Business Overview
Table 168. DIMA Biotechnology IgG4 Antibody Product
Table 169. DIMA Biotechnology Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 170. DIMA Biotechnology Recent Development
Table 171. OriGene Technologies Company Details
Table 172. OriGene Technologies Business Overview
Table 173. OriGene Technologies IgG4 Antibody Product
Table 174. OriGene Technologies Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 175. OriGene Technologies Recent Development
Table 176. Abeomics Company Details
Table 177. Abeomics Business Overview
Table 178. Abeomics IgG4 Antibody Product
Table 179. Abeomics Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 180. Abeomics Recent Development
Table 181. Cayman Chemical Company Details
Table 182. Cayman Chemical Business Overview
Table 183. Cayman Chemical IgG4 Antibody Product
Table 184. Cayman Chemical Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 185. Cayman Chemical Recent Development
Table 186. R&D Systems Company Details
Table 187. R&D Systems Business Overview
Table 188. R&D Systems IgG4 Antibody Product
Table 189. R&D Systems Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 190. R&D Systems Recent Development
Table 191. Biomatik Company Details
Table 192. Biomatik Business Overview
Table 193. Biomatik IgG4 Antibody Product
Table 194. Biomatik Revenue in IgG4 Antibody Business (2020-2025) & (US$ Million)
Table 195. Biomatik Recent Development
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
Table 199. Authors List of This Report


List of Figures
Figure 1. IgG4 Antibody Picture
Figure 2. Global IgG4 Antibody Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global IgG4 Antibody Market Share by Type: 2024 VS 2031
Figure 4. Monoclonal Antibody Features
Figure 5. Polyclonal Antibody Features
Figure 6. Global IgG4 Antibody Market Size by Application (2020-2031) & (US$ Million)
Figure 7. Global IgG4 Antibody Market Share by Application: 2024 VS 2031
Figure 8. Biotechnology Case Studies
Figure 9. Medical Case Studies
Figure 10. University Case Studies
Figure 11. Others Case Studies
Figure 12. IgG4 Antibody Report Years Considered
Figure 13. Global IgG4 Antibody Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global IgG4 Antibody Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global IgG4 Antibody Market Share by Region: 2024 VS 2031
Figure 16. Global IgG4 Antibody Market Share by Players in 2024
Figure 17. Global Top IgG4 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in IgG4 Antibody as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by IgG4 Antibody Revenue in 2024
Figure 19. North America IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America IgG4 Antibody Market Share by Country (2020-2031)
Figure 21. United States IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe IgG4 Antibody Market Share by Country (2020-2031)
Figure 25. Germany IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific IgG4 Antibody Market Share by Region (2020-2031)
Figure 33. China IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America IgG4 Antibody Market Share by Country (2020-2031)
Figure 41. Mexico IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa IgG4 Antibody Market Share by Country (2020-2031)
Figure 45. Turkey IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE IgG4 Antibody Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Bio X Cell Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 49. SouthernBiotech Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 50. MyBioSource Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 51. BosterBio Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 52. Biorbyt Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 53. BioLegend Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 54. Novus Biologicals Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 55. Sino Biological Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 56. RevMAb Biosciences Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 57. RayBiotech Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 58. ichorbio Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 59. Absolute Antibody Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 60. AntibodySystem Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 62. Affinity Immuno Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 63. Dianova Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 64. Southern Biotech Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 65. Leinco Technologies Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 66. Abnova Corporation Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 67. Kyinno Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 68. Cell Sciences Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 69. ProSci Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 70. Bio-Rad Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 71. United States Biological Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 72. DIMA Biotechnology Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 73. OriGene Technologies Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 74. Abeomics Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 75. Cayman Chemical Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 76. R&D Systems Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 77. Biomatik Revenue Growth Rate in IgG4 Antibody Business (2020-2025)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies